Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma

Survey of Ophthalmology

Volumn 49, Issue 5, 2004, Pages 537-540

  Freudenberg, L S ^a,d   Schueler, A O ^b   Beyer, T ^a,c   Antoch, G ^c   Kuhl H ^c   Bornfeld, N ^b   Bockisch, A ^a   Egelhof, T ^c  

^a Departments of Nuclear Medicine

^b Ophthalmology ^*

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

dual modality; fluordeoxyglucose (FDG); positron emission tomography (PET); positron emission tomography computed tomography (PET CT); staging; uveal melanoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CANCER STAGING; CHOROID; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; HUMAN; INTRAOCULAR TUMOR; LIVER METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TREATMENT PLANNING; UVEA MELANOMA; AGED; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ENUCLEATION; FEMALE; MELANOMA; UVEA TUMOR;

AGED; EYE ENUCLEATION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MELANOMA; NEOPLASM STAGING; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED; UVEAL NEOPLASMS;

EID: 7444261543     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2004.06.008     Document Type: Article

References (16)

1. T. Beyer, D.W. Townsend, and T. Brun A combined PET/CT scanner for clinical oncology J Nucl Med 41 2000 1369 1379
2. S. Cutler J. Young Third National Cancer Survey: Incidence Data Vol 41 1975 Bethesda National Cancer Institute
3. M. Diener-West, B.S. Hawkins, J.A. Markowitz, and A.P. Schachat A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988 Arch Ophthalmol 110 1992 245 250
4. A.J. Fischman Positron emission tomography in the clinical evaluation of metastatic cancer J Clin Oncol 14 1996 691 696
5. W.D. Holder, R.L. White, and J.H. Zuger Effectiveness of positron emission tomography for the detection of melanoma metastases Ann Surg 227 1998 764 769 discussion 769-71
6. P.E. Kinahan, D.W. Townsend, T. Beyer, and D. Sashin Attenuation correction for a combined 3D PET/CT scanner Med Phys 25 1998 2046 2053
7. G. Lucignani, G. Paganelli, and G. Modorati MRI, antibody-guided scintigraphy, and glucose metabolism in uveal melanoma J Comput Assist Tomogr 16 1992 77 83
8. G.S. Mijnhout, O.S. Hoekstra, and M.W. van Tulder Systematic review of the diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography in melanoma patients Cancer 91 2001 1530 1542
9. G. Modorati, G. Lucignani, and C. Landoni Glucose metabolism and pathological findings in uveal melanoma: preliminary results Nucl Med Commun 17 1996 1052 1056
10. S.N. Reske, and J. Kotzerke FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000 Eur J Nucl Med 28 2001 1707 1723
11. J. Scotto, F.J. Fraumeni, and J.A.H. Lee Melanomas of the eye and other noncutaneous sites: epidemiologic aspects J Natl Cancer Inst 56 1976 489 491
12. C.L. Shields, J. Cater, and J.A. Shields Combination of clinical factors predictive of growth of small choroidal melanocytic tumors Arch Ophthalmol 118 2000 360 364
13. C.L. Shields, J.A. Shields, and P. De Potter Diffuse choroidal melanoma. Clinical features predictive of metastasis Arch Ophthalmol 114 1996 956 963
14. D.W. Townsend, and S.R. Cherry Combined anatomy and function: the path of true image fusion Eur Radiol 11 2001 1968 1974
15. W.A. Weber, N. Avril, and M. Schwaiger Relevance of positron emission tomography (PET) in oncology Strahlenther Onkol 175 1999 356 373
16. S.R. Wilkes, D.M. Robertson, L.T. Kurland, and R.J. Campbell Incidence of uveal malignant melanoma in the resident population of Rochester and Olmsted County, Minnesota Am J Ophthalmol 87 1979 639 641